Parkin regulates kainate receptors by interacting with the GluK2 subunit

Nature Communications

Volumn 5, Issue , 2014, Pages

  Maraschi, Anna Maria ^a   Ciammola, Andrea ^a   Folci, Alessandra ^b   Sassone, Francesca ^a   Ronzitti, Giuseppe ^c,f   Cappelletti, Graziella ^b   Silani, Vincenzo ^a,b   Sato, Shigeto ^d   Hattori, Nobutaka ^d   Mazzanti, Michele ^b   Chieregatti, Evelina ^c   Mulle, Christophe ^e   Passafaro, Maria ^b   Sassone, Jenny ^a,g  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c ISTITUTO ITALIANO DI TECNOLOGIA   (Italy)

^d JUNTENDO UNIVERSITY   (Japan)

^e UNIVERSITÉ DE BORDEAUX   (France)

^f GÉNÉTHON   (France)

^g DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

KAINIC ACID RECEPTOR; PARKIN; PROTEIN DERIVATIVE; PROTEIN GLUK2; UNCLASSIFIED DRUG; GLUK2 KAINATE RECEPTOR; PROTEIN BINDING; UBIQUITIN PROTEIN LIGASE;

DISEASE INCIDENCE; ENZYME ACTIVITY; MOLECULAR ANALYSIS; MUTATION; NEUROLOGY; PATHOGEN; PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; EXCITOTOXICITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SUBUNIT; UBIQUITINATION; UPREGULATION; ANIMAL; DISEASE MODEL; FEMALE; GENETICS; HUMAN; METABOLISM; NERVE CELL; PARKINSONISM; RAT; TRANSGENIC MOUSE;

ANIMALS; CELL MEMBRANE; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; NEURONS; PARKINSONIAN DISORDERS; PROTEIN BINDING; RATS; RECEPTORS, KAINIC ACID; UBIQUITIN-PROTEIN LIGASES;

EID: 84923351677     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6182     Document Type: Article

References (40)

1. Kitada, T. et al. Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature 392, 605-608 (1998).
2. Tan, E. K. & Skipper, L. M. Pathogenic mutations in Parkinson disease. Hum. Mutat. 28, 641-653 (2007).
3. Shimura, H. et al. Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305 (2000).
4. Vives-Bauza, C. & Przedborski, S. Mitophagy: the latest problem for Parkinson's disease. Trends Mol. Med. 17, 158-165 (2011).
5. Youle, R. J. & Narendra, D. P. Mechanisms of mitophagy. Nat. Rev. Mol. Cell. Biol. 12, 9-14 (2011).
6. Helton, T. D., Otsuka, T., Lee, M. C., Mu, Y. & Ehlers, M. D. Pruning and loss of excitatory synapses by the parkin ubiquitin ligase. Proc. Natl Acad. Sci. USA 105, 19492-19497 (2008).
7. Fallon, L. et al. Parkin and CASK/LIN-2 associate via a PDZ-mediated interaction and are co-localized in lipid rafts and postsynaptic densities in brain. J. Biol. Chem. 277, 486-491 (2002).
8. Joch, M. et al. Parkin-mediated monoubiquitination of the PDZ protein PICK1 regulates the activity of acid-sensing ion channels. Mol. Biol. Cell 18, 3105-3118 (2007).
9. Trempe, J. F. et al. SH3 domains from a subset of BAR proteins define a Ublbinding domain and implicate parkin in synaptic ubiquitination. Mol. Cell 36, 1034-1047 (2009).
10. Staropoli, J. F. et al. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron 37, 735-749 (2003).
11. Hattori, N. et al. Molecular genetic analysis of a novel Parkin gene in Japanese families with autosomal recessive juvenile parkinsonism: evidence for variable homozygous deletions in the Parkin gene in affected individuals. Ann. Neurol. 44, 935-941 (1998).
12. Lu, X. H. et al. Bacterial artificial chromosome transgenic mice expressing a truncated mutant parkin exhibit age-dependent hypokinetic motor deficits, dopaminergic neuron degeneration, and accumulation of proteinase K-resistant alpha-synuclein. J. Neurosci. 29, 1962-1976 (2009).
13. Coussen, F. & Mulle, C. Kainate receptor-interacting proteins and membrane trafficking. Biochem. Soc. Trans. 34, 927-930 (2006).
14. Shimura, H. et al. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Science 293, 263-269 (2001).
15. Martin, S., Nishimune, A., Mellor, J. R. & Henley, J. M. SUMOylation regulates kainate-receptor-mediated synaptic transmission. Nature 447, 321-325 (2007).
16. Paternain, A. V., Morales, M. & Lerma, J. Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons. Neuron 14, 185-189 (1995).
17. Verdoorn, T. A., Johansen, T. H., Drejer, J. & Nielsen, E. O. Selective block of recombinant glur6 receptors by NS-102, a novel non-NMDA receptor antagonist. Eur. J. Pharmacol. 269, 43-49 (1994).
18. Harris, A. S. & Morrow, J. S. Proteolytic processing of human brain alpha spectrin (fodrin): identification of a hypersensitive site. J. Neurosci. 8, 2640-2651 (1988).
19. Staszewski, R. D. & Yamamoto, B. K. Methamphetamine-induced spectrin proteolysis in the rat striatum. J. Neurochem. 96, 1267-1276 (2006).
20. Wu, H. Y. et al. Critical role of calpain-mediated cleavage of calcineurin in excitotoxic neurodegeneration. J. Biol. Chem. 279, 4929-4940 (2004).
21. Wang, X. et al. PINK1 and parkin target miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 147, 893-906 (2011).
22. Contractor, A., Mulle, C. & Swanson, G. T. Kainate receptors coming of age: milestones of two decades of research. Trends Neurosci. 34, 154-163 (2011).
23. Spratt, D. E., Walden, H. & Shaw, G. S. RBR E3 ubiquitin ligases: new structures, new insights, new questions. Biochem. J. 458, 421-437 (2014).
24. Zhang, Y. et al. Parkin functions as an E2-dependent ubiquitin-protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc. Natl Acad. Sci. USA 97, 13354-13359 (2000).
25. Choi, P. et al. SEPT5-v2 is a parkin-binding protein. Brain Res. Mol. Brain Res. 117, 179-189 (2003).
26. Trempe, J. F. et al. Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science 340, 1451-1455 (2013).
27. Wauer, T. & Komander, D. Structure of the human Parkin ligase domain in an autoinhibited state. EMBO J. 32, 2099-2112 (2013).
28. Dawson, T. M. Unraveling the role of defective genes in Parkinson's disease. Parkinsonism Relat. Disord. 13, S248-S249 (2007).
29. Lavoie, B. & Parent, A. Pedunculopontine nucleus in the squirrel monkey: cholinergic and glutamatergic projections to the substantia nigra. J. Comp. Neurol. 344, 232-241 (1994).
30. Comoli, E. et al. A direct projection from superior colliculus to substantia nigra for detecting salient visual events. Nat. Neurosci. 6, 974-980 (2003).
31. Sadikot, A. F., Parent, A., Smith, Y. & Bolam, J. P. Efferent connections of the centromedian and parafascicular thalamic nuclei in the squirrel monkey: a light and electron microscopic study of the thalamostriatal projection in relation to striatal heterogeneity. J. Comp. Neurol. 320, 228-242 (1992).
32. Lozano, A. M., Dostrovsky, J., Chen, R. & Ashby, P. Deep brain stimulation for Parkinson's disease: disrupting the disruption. Lancet Neurol. 1, 225-231 (2002).
33. Olanow, C. W. & Tatton, W. G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22, 123-144 (1999).
34. Bischoff, S., Barhanin, J., Bettler, B., Mulle, C. & Heinemann, S. Spatial distribution of kainate receptor subunit mRNA in the mouse basal ganglia and ventral mesencephalon. J. Comp. Neurol. 379, 541-562 (1997).
35. Rodriguez, M. C., Obeso, J. A. & Olanow, C. W. Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection. Ann. Neurol. 44, S175-S188 (1998).
36. Yang, F. et al. Parkin stabilizes microtubules through strong binding mediated by three independent domains. J. Biol. Chem. 280, 17154-17162 (2005).
37. Coussen, F. et al. Recruitment of the kainate receptor subunit glutamate receptor 6 by cadherin/catenin complexes. J. Neurosci. 22, 6426-6436 (2002).
38. Valnegri, P. et al. A circadian clock in hippocampus is regulated by interaction between oligophrenin-1 and Rev-erbα. Nat. Neurosci. 14, 1293-1301 (2011).
39. Ma-Högemeier, Z. L. et al. Oligomerization in the endoplasmic reticulum and intracellular trafficking of kainate receptors are subunit-dependent but not editing-dependent. J. Neurochem. 113, 1403-1415 (2010).
40. Bassani, S. et al. The X-linked intellectual disability protein TSPAN7 regulates excitatory synapse development and AMPAR trafficking. Neuron 73, 1143-1158 (2012).